Similar articles

• Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.

  Bruni B, Gamba S, Regis G, Turco GL. Bruni B, et al. Diabetologia. 1978 Mar;14(3):165-9. doi: 10.1007/BF00429776. Diabetologia. 1978. PMID: 566232
• Behaviour of insulin antibodies in diabetics treated with different insulins.

  Mincu I, Cheţa D, Ionescu-Tîrgovişte C, Mirodon Z, Sîntu E. Mincu I, et al. Med Interne. 1980 Oct-Dec;18(4):347-52. Med Interne. 1980. PMID: 7006044
• [Serum levels of insulin-binding antibodies treated with monocomponent insulin].

  Czyzyk A, Lawecki J, Rogala H, Miedzińska E, Popik-Hankiewicz A. Czyzyk A, et al. Pol Tyg Lek. 1974 Feb 25;29(8):301-4. Pol Tyg Lek. 1974. PMID: 4856084 Polish. No abstract available.
• [Insulin-binding antibodies and insulin resistance (author's transl)].

  Waldhäusl W. Waldhäusl W. Wien Klin Wochenschr. 1973 Dec 21;85(51):833-6. Wien Klin Wochenschr. 1973. PMID: 4272340 Review. German. No abstract available.
• [Antidiabetics. 42].

  Jacker HJ. Jacker HJ. Pharm Prax. 1969 Dec;12:270-9. Pharm Prax. 1969. PMID: 4913446 Review. German. No abstract available.